vs
太平洋生物科学（ASMB）与CF BANKSHARES INC.（CFBK）财务数据对比。点击上方公司名可切换其他公司
CF BANKSHARES INC.的季度营收约是太平洋生物科学的1.5倍（$15.7M vs $10.8M），CF BANKSHARES INC.净利率更高（40.0% vs -85.2%，领先125.3%），太平洋生物科学同比增速更快（57.6% vs 12.6%），CF BANKSHARES INC.自由现金流更多（$18.2M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
CF BANKSHARES INC.是一家美国区域性银行控股企业，通过旗下社区银行子公司运营，提供全方位个人及商业银行解决方案，包括存款产品、各类贷款、财富管理服务及数字银行工具，主要服务美国中西部地区的个人消费者和中小企客户。
ASMB vs CFBK — 直观对比
营收规模更大
CFBK
是对方的1.5倍
$10.8M
营收增速更快
ASMB
高出45.0%
12.6%
净利率更高
CFBK
高出125.3%
-85.2%
自由现金流更多
CFBK
多$33.4M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $15.7M |
| 净利润 | $-9.2M | $5.7M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 43.4% |
| 净利率 | -85.2% | 40.0% |
| 营收同比 | 57.6% | 12.6% |
| 净利润同比 | 4.3% | 29.9% |
| 每股收益（稀释后） | $-0.72 | $0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBCFBK
| Q4 25 | — | $15.7M | ||
| Q3 25 | $10.8M | $15.5M | ||
| Q2 25 | $9.6M | $15.6M | ||
| Q1 25 | $9.4M | $14.1M | ||
| Q4 24 | $7.4M | $14.0M | ||
| Q3 24 | $6.8M | $13.1M | ||
| Q2 24 | $8.5M | $12.6M | ||
| Q1 24 | $5.8M | $12.2M |
净利润ASMBCFBK
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-9.2M | $2.3M | ||
| Q2 25 | $-10.2M | $5.0M | ||
| Q1 25 | $-8.8M | $4.4M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $-9.6M | $4.2M | ||
| Q2 24 | $-11.2M | $1.7M | ||
| Q1 24 | $-9.1M | $3.1M |
营业利润率ASMBCFBK
| Q4 25 | — | 43.4% | ||
| Q3 25 | -100.9% | 17.5% | ||
| Q2 25 | -115.2% | 41.1% | ||
| Q1 25 | -105.5% | 39.5% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | -160.1% | 40.4% | ||
| Q2 24 | -143.0% | 15.4% | ||
| Q1 24 | -185.5% | 30.9% |
净利率ASMBCFBK
| Q4 25 | — | 40.0% | ||
| Q3 25 | -85.2% | 15.1% | ||
| Q2 25 | -105.9% | 32.3% | ||
| Q1 25 | -93.6% | 31.4% | ||
| Q4 24 | — | 35.2% | ||
| Q3 24 | -140.4% | 32.2% | ||
| Q2 24 | -130.7% | 13.5% | ||
| Q1 24 | -156.9% | 25.2% |
每股收益（稀释后）ASMBCFBK
| Q4 25 | — | $0.88 | ||
| Q3 25 | $-0.72 | $0.36 | ||
| Q2 25 | $-1.33 | $0.77 | ||
| Q1 25 | $-1.17 | $0.68 | ||
| Q4 24 | — | $0.68 | ||
| Q3 24 | $-1.51 | $0.65 | ||
| Q2 24 | $-1.98 | $0.26 | ||
| Q1 24 | $-1.66 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $259.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $184.4M |
| 总资产 | $240.0M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBCFBK
| Q4 25 | — | $259.0M | ||
| Q3 25 | $22.5M | $272.4M | ||
| Q2 25 | $24.0M | $275.7M | ||
| Q1 25 | $23.4M | $241.0M | ||
| Q4 24 | $38.3M | $235.3M | ||
| Q3 24 | $28.5M | $233.5M | ||
| Q2 24 | $19.2M | $241.8M | ||
| Q1 24 | $18.7M | $236.9M |
股东权益ASMBCFBK
| Q4 25 | — | $184.4M | ||
| Q3 25 | $182.7M | $179.3M | ||
| Q2 25 | $18.1M | $177.0M | ||
| Q1 25 | $27.1M | $172.7M | ||
| Q4 24 | $33.4M | $168.4M | ||
| Q3 24 | $26.0M | $164.0M | ||
| Q2 24 | $34.7M | $159.6M | ||
| Q1 24 | $32.6M | $158.0M |
总资产ASMBCFBK
| Q4 25 | — | $2.1B | ||
| Q3 25 | $240.0M | $2.1B | ||
| Q2 25 | $80.8M | $2.1B | ||
| Q1 25 | $99.0M | $2.1B | ||
| Q4 24 | $119.2M | $2.1B | ||
| Q3 24 | $100.3M | $2.1B | ||
| Q2 24 | $115.3M | $2.0B | ||
| Q1 24 | $119.9M | $2.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $18.7M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $18.2M |
| 自由现金流率自由现金流/营收 | -140.7% | 115.6% |
| 资本支出强度资本支出/营收 | 0.4% | 3.1% |
| 现金转化率经营现金流/净利润 | — | 3.26× |
| 过去12个月自由现金流最近4个季度 | — | $33.4M |
8季度趋势，按日历期对齐
经营现金流ASMBCFBK
| Q4 25 | — | $18.7M | ||
| Q3 25 | $-15.1M | $5.5M | ||
| Q2 25 | $-16.8M | $8.0M | ||
| Q1 25 | $-23.4M | $2.2M | ||
| Q4 24 | $-51.1M | $14.2M | ||
| Q3 24 | $-15.2M | $-1.3M | ||
| Q2 24 | $-17.1M | $4.0M | ||
| Q1 24 | $-18.4M | $-1.2M |
自由现金流ASMBCFBK
| Q4 25 | — | $18.2M | ||
| Q3 25 | $-15.2M | $5.2M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | $-51.1M | $13.9M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | $-17.1M | $4.0M | ||
| Q1 24 | $-18.4M | $-1.2M |
自由现金流率ASMBCFBK
| Q4 25 | — | 115.6% | ||
| Q3 25 | -140.7% | 33.6% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 15.2% | ||
| Q4 24 | -695.2% | 99.6% | ||
| Q3 24 | — | -9.9% | ||
| Q2 24 | -200.6% | 31.6% | ||
| Q1 24 | -317.7% | -9.5% |
资本支出强度ASMBCFBK
| Q4 25 | — | 3.1% | ||
| Q3 25 | 0.4% | 1.7% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.4% | ||
| Q4 24 | 0.4% | 1.9% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率ASMBCFBK
| Q4 25 | — | 3.26× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 3.21× | ||
| Q3 24 | — | -0.30× | ||
| Q2 24 | — | 2.35× | ||
| Q1 24 | — | -0.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
